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Abstract
Background:  The  complexity  of  motor  and  nonmotor  symptoms  in  patients  with
Parkinson's disease (PD) requires multidisciplinary health actions.
Objective: To describe the role of nurses as members of multidisciplinary teams tasked
with treatment of motor and nonmotor symptoms and provide nursing protocols for the
care of patients with Parkinson's disease.
Methods: Analysis of the main diagnoses, outcomes, and ICNP® interventions identified
by cross‐mapping empirical evidence described in 2123 nursing documents and data
from medical records of patients with Parkinson's disease in the specialized rehabilita‐
tion program at the Sarah Network of Rehabilitation Hospitals in Brazil. The protocols
were based on scientific evidence and international recommendations.
Results: Clinical nursing protocols were developed based on a standardized nursing
language of diagnoses, outcomes, and interventions focused on motor and nonmotor
symptoms and principles of rehabilitation.
Conclusion: These protocols are expected to guide the clinical reasoning of nurses for
comprehensive care of patients with Parkinson's disease and their families.
Keywords: Parkinson's disease, nursing role, specialist nurses, rehabilitation nurses,
multidisciplinary teams
1. Introduction
Parkinson's disease (PD) affects approximately 1% of women and men worldwide, especial‐
ly those over the age of 60 [1]. It is a multisystem and neurodegenerative disease with genetic
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and environmental factors that result in deficits in the production of neurotransmitters,
including dopamine [2].
PD is diagnosed through a clinical evaluation of motor symptoms; the presence of nonmo‐
tor symptoms combined with the current lack of cure reflects the complexity of health care,
which aims to control symptoms in order to maintain the quality of life of the patient and
family [3–5].
Currently, health system remodelling is observed for the development of guidelines with
multidisciplinary actions that address the complexity of care [6, 7].
Enabling health professionals with specific areas of knowledge allows standardization of
behaviors that will minimize the challenges of interprofessional collaboration.
In this context, nursing care of patients with PD must focus on the biopsychosocial context and
must be based on ethical, legal, operational, and theoretical assumptions of the profession for
health promotion, prevention of complications, treatment, and rehabilitation [8].
Thus, the clinical reasoning of nurses should be based on the pathophysiology of the disease
as well as the nursing process and should be structured in a standardized language for
communication with other professionals on the team. Standardization of the nursing lan‐
guage enables communication and comparison of data between different contexts, countries,
and languages, and maximizes dissemination of knowledge from clinical data [9, 10].
Among existing nursing terminologies is the International Classification for Nursing
Practice (ICNP®), which was developed by the International Council of Nurses and is
integrated into the family of international classifications of the World Health Organization [9].
This terminology allows development of terminological subsets of diagnoses, outcomes, and
interventions targeted to specific areas of clinical nursing practice.
2. The role of nurses in Parkinson's disease
Research has shown increasing specialization among nurses who care for patients with PD
[11–13]; thus, knowledge of the pathophysiology of this disease is arguably an important
starting point for vocational training [14]. Based on this, we sought to hierarchically organize
the major motor and nonmotor symptoms of PD using evidence gathered from the literature
(Figure 1).
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Figure 1. Classification of the main motor and nonmotor symptoms in Parkinson's disease.
The symptoms of PD are divided into motor and nonmotor; each of these classifications
contains various other signs and symptoms related to both the neurodegenerative disease
process itself as well as multifactorial causes. Thus, hierarchical organization of symptoms is
not an easy task, and various descriptions have been proposed to facilitate understanding of
the pathophysiology of the disease [15–18]; however, none of them have structured the
symptoms into an organizational chart.
Our research on nursing diagnoses, outcomes, and interventions was based on this chart.
2.1. Nursing diagnoses/outcomes and interventions of ICNP® for patients with
Parkinson's disease in rehabilitation
We analyzed 2123 nursing documentations from 352 medical records of patients with PD who
participated in a rehabilitation program at a specialized centre in Rio de Janeiro, Brazil, from
May 2009 to March 2014. From these documents, empirical evidence regarding nursing
diagnoses, outcomes, and interventions was extracted. These dates were cross‐mapped with
ICNP® 2013 and validated by judges (nurses) to build a terminological subset of ICNP® for
patients with PD in rehabilitation [19].
The diagnoses, outcomes, and interventions were divided into categories including motor
symptoms, nonmotor symptoms, and principles of rehabilitation, as shown in Figure 2.
Greater variability was observed in nursing diagnoses, outcomes, and interventions related
to nonmotor symptoms of Parkinson's disease; in general, it appears that nurses work in a
comprehensive and communicative manner with other professionals on multidisciplinary
teams.
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Figure 2. The main Nursing Diagnoses/Outcomes and Interventions of Parkinson's disease mapped according to
ICNP®.
2.1.1. Nursing diagnoses and outcomes related to motor symptoms, self‐care, and safety
The motor symptoms of PD include resting tremor, muscle rigidity, bradykinesia, and postural
instability. These symptoms were described in 1817 in a monograph by James Parkinson and
are currently considered the cardinal signs for clinical diagnosis of the disease [20]. In the
ICNP®, these symptoms are represented by the diagnoses and outcomes tremor, hypoactivity,
and risk for fall.
2.1.1.1. Tremor
Resting tremor affects up to 75% of the patients with PD. It is characterized by involuntary
tremors of the hands, lips, and jaw 4–6 Hz in intensity. They occur at rest but may worsen in
stressful situations or while walking and stopping when actions are performed by the affected
limb [21].
2.1.1.2. Hypoactivity
Muscle rigidity and bradykinesia are represented in the ICNP® by the term hypoactivity. This
is a broad term that can be considered a syndrome that encompasses several specific terms
corresponding to this diagnosis.
Muscle rigidity is characterized by disharmony of the flexor and extensor muscles, compro‐
mising joint mobility by making them rigid. Rigidity may lead to motor symptoms, among
other problems, evidenced by reduced handwriting capacity, which is referred to as a
micrograph in PD and is represented in the ICNP® by the term impaired psychomotor activity.
Its prevalence in this population ranges from 10 to 63.2% [22].
Bradykinesia is defined as difficulty and slowness in initiating movement. It may affect the
ability to perform simultaneous tasks and slow reaction times [14] and is associated with other
disorders, such as decreased arm balance, hypomimia, and hypokinetic dysarthria, which are
encompassed by the ICNP® terms slurred speech and impaired ability to communicate by talking.
Decreased arm balance occurs asymmetrically in the early stages of PD [3]. Hypomimia is
defined as the reduction of voluntary orofacial movements that result in reduced facial
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expression in patients with PD. These symptoms may be related to bradykinesia [3], as well
as other cognitive disorders that impair emotional recognition of facial expression [23].
Lack of motor control speech, called hypokinetic dysarthria, affects about 90% of patients with
PD. It is characterized by deficits in vocalization related to the variation in the height and
intensity during speech [24–26]. Its pathophysiological mechanisms have been studied, and
there is empirical evidence that in addition to motor mechanisms associated with bradykine‐
sia, cognitive mechanisms of self‐perception, and self‐monitoring of speech are involved [24,
25].
2.1.1.3. Risk for fall
Postural instability is related to the loss of postural reflexes, which occurs in the later stages of
PD. Instability is measured by retropulsion or propulsion tests. Postural instability is de‐
fined as more than two steps backward or forward, or when there is an absence of postural
response. This symptom is the most common cause of falls and contributes significantly to the
risk of fractures [17].
2.1.1.4. Lack of knowledge of disease or self‐care deficit
Knowledge about the disease and its symptoms promotes better patient and family manage‐
ment of limitations. The role of the family, both to encourage maximum independence in the
patient's activities of daily living and to provide compensatory care for the deficits, is not an
easy task. Thus, identification of these diagnoses is considered the starting point of the
rehabilitation program.
2.1.2. Nursing diagnoses and outcomes related to nonmotor symptoms
The hierarchical organization of nonmotor symptoms includes disautonomic (urogenital,
gastrointestinal, cardiovascular, and thermoregulation), sleep, neurobehavioral (mood,
cognition, and psychiatric), sensory, and other subdivisions. In the ICNP®, these symptoms
are represented by diagnoses and results, including impaired urinary system process,
impotence, impaired gastrointestinal system process, hypotension, impaired sleep, impaired
mood equilibrium, impaired cognition, and altered perception.
2.1.2.1. Impaired urinary system process
Bladder urogenital symptoms may be present in up to 96% of the patients with PD; they are
characterized as storage symptoms (urgency, urge incontinence, increased daytime urinary
frequency above eight micturitions, and two or more nocturnal micturitions) and emptying
symptoms (hesitancy, decreased, or intermittent urine stream, sensation of incomplete
emptying, and urinary retention) [27, 28].
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2.1.2.2. Impotence
Sexual dysfunctions are the result of neurodegeneration and include difficulty with erection,
loss of libido, and lack of orgasm. However, patients may also experience the opposite
symptoms, mainly related to dopamine agonist therapy, which are characterized by obses‐
sions or compulsions related to sex [15, 16].
2.1.2.3. Impaired gastrointestinal system process
In the ICNP® the diagnosis or outcome impaired gastrointestinal system process is also consid‐
ered a broad term that may include specific diagnoses related to the same problem.
In PD, degenerative impairment of the vagus nerve, which is responsible for nervous control
of the esophagus, stomach, and intestine via the parasympathetic and spinal cord system,
causes dysfunction of the motility of the entire gastrointestinal tract, resulting in the follow‐
ing symptoms: oropharyngeal dysphagia (impaired swallowing), gastric stasis, constipation or
slow motility (constipation), and sphincter dyssynergism and drooling (abnormal salivation)
related to the decrease or absence of the swallowing reflex, which leads to the accumulation
of saliva in the mouth [29, 30]. A review study also revealed that drooling may be related to
both increased saliva production and slowed orofacial movements [31].
2.1.2.4. Hypotension
Orthostatic hypotension can result in dizziness during position changes (particularly to a
standing position), fatigue, and even fainting and falls. This symptom may be subtle in early
PD and does not necessarily worsen with disease progression [15, 16]. It affects about 40–60%
of patients with PD, but only 20% may be symptomatic [32]. Supine hypertension, described
in the organizational chart, is a sign recently debated among scientists who are in the early
stages of studies on the pathophysiological mechanisms [33]. What we do know is that this
symptom usually coexists with hypotension, both related to changes in the circadian rhythms
of blood pressure [34].
2.1.2.5. Impaired sleep
Sleep disorders are very prevalent in patients with PD and have been studied extensively by
scientists. Their pathophysiology is complex and results in overall impairment of the sleep–
wake cycle [35, 36]. These disorders may negatively affect many biological functions and
enhance associated symptoms such as cognitive, neuropsychiatric, and fatigue and affect
quality of life of the patient/family [37].
2.1.2.6. Impaired mood equilibrium
Among neurobehavioral symptoms, mood disorders are present in 40–70% of patients with
PD. The pathophysiological mechanisms of neurotransmitter regulation are demonstrably
involved in the causes of depression (depression), apathy (low initiative), and social isolation
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(impaired socialisation) [16, 38, 39]. However, it is important to consider the impact of other
symptoms, including motor symptoms, on the mood of patients with this disease [39].
2.1.2.7. Impaired cognition
The cognitive (minimum cognitive impairment and dementia) and neuropsychiatric (halluci‐
nation, delusion, illusion, and impulses control disorder) impairments associated with PD also
have a complex pathophysiology; the manifestations vary in severity, tending to worsen with
disease progression [39]. They deserve special attention from multidisciplinary health teams
as they may endanger patient's health and overwhelm patient's families and caregivers [40].
2.1.2.8. Altered perception
Sensory symptoms directly related to the pathophysiology of PD include hyposmia and
anosmia, ageusia, pain, and paresthesia [15, 16, 39, 41]. Fatigue has also been recently studied
as an additional symptom. The prevalence of altered perception ranges from 33 to 58% and
may be related to depression and apathy, sleep changes, cardiovascular dysfunction, motor
symptoms, drug use, or insufficient blood flow in the frontal lobe [41].
2.1.2.9. Body weight problem
One review study described weight loss as a very common symptom in patients with PD, who
have low body mass indexes compared with those of healthy controls matched by sex and age.
The etiology has been described as multifactorial, related to motor symptoms, changes in
eating habits, and medication use (especially levodopa) in addition to being potentially related
to physiological changes in the neurodegenerative process [39].
2.1.3. Nursing diagnoses related to the principles of rehabilitation
Most of the symptoms of Parkinson's disease can be controlled by drugs, which make it
necessary to assess patient adherence to treatment.
Drug treatment regimens for PD are complex since the variability in symptoms denotes the
necessity of drug combination subdivided into smaller doses over 24 hours [42]. While the
indication and prescription of drugs are obviously performed by physicians, nurses play an
important role in treatment adherence.
There are several reasons why patients may not adhere to drug treatment, which are classi‐
fied as intentional and unintentional [43].
2.1.3.1. Lack of knowledge of medication regime and negative response to medication
One of the unintentional reasons for compromised treatment adherence is a lack of patient's
understanding on the importance of treatment. Patients often believe that drug therapy will
cure their symptoms, not realizing that the therapy is aimed at reducing their severity in order
to promote better quality of life. Moreover, the presence of motor fluctuations and complica‐
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tions of the therapy itself promotes disbelief regarding the effectiveness of treatment, which
in turn contributes to nonadherence.
2.1.3.2. Medication supply deficit and impaired ability to manage medication regime
The factors associated with unintentional nonadherence are often a result of poor access to
treatment because of the high cost of medications. Likewise, unintentional nonadherence may
result from the patient's inability to self‐manage their medications. This inability may result
from cognitive deficits, education level, and cultural, religious, and behavioral factors.
Thus, accurate assessment of the causes of nonadherence to drug therapy in patients with PD
underscores the importance of the nursing care plan, which therefore will complement
multiprofessional health actions focused on the patient, promoting improvement of their
quality of life through better control of their symptoms.
2.1.3.3. Impaired quality of life and socialisation, inadequate routine, and caregiver stress
The impact of the disease on routine activities, socialization, and quality of life of patients who
are affected by the symptoms of PD may compromise their independence in performing the
activities of daily life as well as their professional lives. In a ripple effect, these problems will
results in individual, family, and social losses [13, 44, 45].
2.1.4. Nursing interventions related to nonmotor and motor symptoms and principles of rehabilitation
2.1.4.1. “Teaching” interventions
Among the main nursing interventions mapped, those related to educational practice and used
by nurses as the main tool for health promotion were of particular importance.
Health education is considered a change of strategy in care models and is an alternative used
to improve the quality of health and life of the population through increased understanding
of health and disease [46].
Health promotion actions in neurological rehabilitation facilitate recovery and adaptation to
the limitations imposed by disabilities on individual and contextualized bases. These actions
mainly focus on functional, motor, psychosocial, and spiritual aspects [46].
Therefore, it is imperative for nurses to establish bonds with patients and their families when
providing orientations in order to promote facilitation and implementation of learning. In this
coparticipatory relationship, the focus is on personal autonomy for affirmation of the princi‐
ples of citizenship and democracy, with the aim to improve health status [46].
2.1.4.2. “Referring” interventions
We highlight the interventions that reveal the important role played by interprofessional
nurses, which are based on the best evidence to identify symptoms and collaborate with the
team through discussion and referral of patients for evaluation. These interventions show that
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nurses are often the connection point with other members of the professional team in order to
provide holistic care [47].
2.2. Nursing protocols for patients with Parkinson's disease
Accurate identification of nursing diagnoses is essential for clinical practice since it enables
proper planning of care, implementation of interventions, and efficient evaluation of the
results.
Therefore, it is necessary to use diagnostic support tools prepared in accordance with
institutional settings and the complexity of patient's conditions. These tools should still be
based on the best clinical evidence and recommendations described in the scientific literature.
This subchapter presents several nursing assessment protocols in the context of the activities
of daily living, gastrointestinal and genitourinary function, sleep disorders, hypotension, and
medication adherence.
Nursing assessment for daily life activities in patients with Parkinson's disease
Date: _____/_____/_______
Personal data
Name: _________________ Age: ___ Sex: ( ) Female ( ) Male Family/Caregiver:________________
Date of onset of symptoms of Parkinson's disease: _________________________________________
Concomitant diseases: ______________ Daily medications: __________________________________
Housing conditions and family support
( ) Own residence ( ) Rented residence ( ) Residence of relatives/friends ( ) Institutionalized
( ) House with a single level ( ) House with multiple levels ( ) Stairs with unilateral handrail ( ) Stairs with bilateral
handrail ( ) Stairs without handrail ( ) No stairs ( ) Apartment with elevator ( ) Apartment with no elevator
Adaptation at residence? ( ) yes ( ) no Where?__________________________________________
( ) Live alone ( ) Live with whom? _______________________ Family/caregiver support? ( ) Yes ( ) No
Routine
Describe your routine before the Parkinson's disease diagnosis:_______________________________
__________________________________________________________________________________
Describe your current routine:__________________________________________________________
__________________________________________________________________________________
Schwab and England activities of daily living [48]
100%-Completely independent. Able to do all chores without slowness, difficulty, or impairment. Essentially normal.
Unaware of any difficulty.
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90%-Completely independent. Able to do all chores with some degree of slowness, difficulty, and impairment. Might
take twice as long. Beginning to be aware of difficulty.
80%-Completely independent in most chores. Takes twice as long. Conscious of difficulty and slowness.
70%-Not completely independent. More difficulty with some chores. Three to four times as long in some. Must spend a
large part of the day with chores.
60%-Some dependency. Can do most chores but exceedingly slowly and with much effort. Errors; some impossible.
50%-More dependent. Help with half, slower, et cetera. Difficulty with everything.
40%-Very dependent. Can assist with all chores, but few alone.
30%-With effort, now and then does a few chores alone or begins alone. Much help needed.
20%-Nothing alone. Can be a slight help with some chores. Severe invalid.
10%-Total dependent, helpless. Complete invalid.
0%-Vegetative functions such as swallowing, bladder, and bowel functions are not functioning. Bed-ridden.
MDS-UPDRS Part II scale can be applied
Nursing diagnoses Nursing interventions
Evaluation of patient's ability to perform activities of daily life is complex because it in‐
volves environmental aspects (usually related to the accessibility of the house), family support
or caregivers, and commitment to the routine. The assessment should be based on standar‐
dized scales, such as the Unified Parkinson's Disease Rating Scale (UPDRS) Part II and the
Schwab and England activities of daily living scales widely used in research and clinical
practice [48–50].
Nursing assessment of bowel status in patients with Parkinson's disease
Date: _____/_____/_______
Personal data
Name: ______________ Age: ____ Sex: ( ) Female ( ) Male Family/Caregiver:________________





Onset of symptoms: _____ Presence of symptoms before PD: ( ) Yes ( ) No How many years? ______
Background surgical gastrointestinal tract: ( ) Yes ( ) No What: _______________________________
Regular monitoring by gastroenterologist: ( ) Yes ( ) No
Feel the urge for bowel movement? ( ) Several times/day ( ) Daily ( ) Every 1-2 days ( ) Every 1-_ days
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Flatulence? ( ) Never ( ) Sometimes ( ) Often ( ) Always
Fecal Incontinence? ( ) Never ( ) Sometimes ( ) Often ( ) Always
When does fecal incontinence occur? (You can mark more than one answer)
( ) During a diarrheal episode ( ) Every time because of the urgency ( ) When coughing and rising ( ) Unexpectedly
Rome III Criteria [51]
Must include two or more of the following:
( ) Straining during at least 25% of defecations
( ) Lumpy or hard stools in at least 25% of defecations
( ) Sensation of incomplete evacuation for at least 25% of defecations
( ) Sensation of anorectal obstruction/blockage for at least 25% of defecations
( ) Manual maneuvers to facilitate at least 25% of defecations (e.g., digital evacuation)
( ) Fewer than three defecations per week
* Criteria fulfilled for the last three months with symptom onset at least six months prior to diagnosis
Bristol scale
In most evacuations, what is the characteristic of the feces? ___________________________
Devices for evacuation Complications
( ) External device for evacuation ( ) Toilet
( ) Diapers
( ) Have you ever undergone intestinal cleansing
( ) Laxatives/or antigas medication Which?_______
How often do you use laxative or antigas




( ) Other: _____________________________
Mobility
Are you dependent on others for evacuation: ( ) Yes ( ) No
Transfer to lavatory seat: ( ) Independent ( ) Dependent
Locomotion: ( ) Without assistance and without support ( ) Locomotion assistance
Self-care
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Dependant on others to eat and/or drink ( ) Yes ( ) No Why?____________ Daily water intake ______
Low tolerance for liquids? ( ) Yes ( ) No Do you have adipsia? ( ) Yes ( ) No









Dependant on others? ( ) Yes ( ) No Why?_______________________________________________
Cognitive disorders? ( ) Yes ( ) No What: ______________________________________________
Behavioral disorders? ( ) Yes ( ) No What: ______________________________________________
Housing conditions
Easy access to the bathroom: ( ) Yes ( ) No
Modifications made to bathroom/home: ( ) Yes ( ) No What? ________________________________
Modifications to the bathroom/home are required: ( ) Yes ( ) No What? ________________________
Community, social, and civic life
Impact on labour activities related to constipation ( ) Yes ( ) No ( ) Not applicable
Impact on leisure activities related to constipation ( ) Yes ( ) No
Impact on quality of life related to constipation ( ) Yes ( ) No




- Contour: ( ) Plan ( ) Excavated ( ) Globular
- Symmetry: _______________________________________________________________________
Abdominal auscultation (Intestinal noises): ( ) 2 to 5/min ( ) < 2 to 5/min ( ) > than 2 to 5/min
Percussion: ( ) Tympanic ( ) Hypertympanic ( )Massive Quadrant:____________________________
Abdominal palpation: _______________________________________________________________
Nursing diagnoses Nursing interventions
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Evaluation of intestinal symptoms in patients with PD focuses on constipation, which is the
main problem. However, it is important to assess other symptoms such as fecal incontinence
and related factors that enhance intestinal symptoms such as changes in mobility/accessibili‐
ty, swallowing, and cognitive function, among others. The Rome III criteria and the Bristol
Stool Scale are recommended tools for evaluation of constipation [51, 52].
Genitourinary nursing assessment in patients with Parkinson's disease
Date: _____/_____/_______
Personal data
Name: ______________ Age: ___ Sex: ( ) Female ( ) Male Family/Caregiver:____________________
Date of onset of symptoms of Parkinson's disease: __________________________________________
Concomitant diseases: ________________________________________________________________
Daily medications: ___________________________________________________________________
Genitourinary, reproductive, and bowel functions
Number of pregnancies and births: _________ ( ) Vaginal birth ( ) Caesarean ( ) Abortions: _________
Main complaint: _____________________________________________________________________
Onset of symptoms: _________________ Presence of symptoms before PD: ( ) Yes ( ) No
History of uro/gynaecology surgery: ( ) Yes ( ) No Which: ___________________________________
Regular monitoring by urologist/gynaecologist: ( ) Yes ( ) No
Sensation of bladder fullness ( ) Yes ( ) No
Bladder control ( ) Yes ( ) No Urinary Urgency ( ) Yes ( ) No Urinary Loss ( ) Yes ( ) No
Intestinal function: ( ) Regular ( ) Irregular Frequency:______________________________________
Do the bladder symptoms impact sexual capacity ( ) Yes ( ) No How? __________________________
Storage symptoms
( ) Urinary Urgency ( ) Urge Incontinence
( ) Stress incontinence ( ) Enuresis
( ) Increased frequency of diurnal urinary
( ) Nocturia. How many times?________
Voiding symptoms
( )Decreased urinary stream( )Hesitation
( )Urinary flow intermittent ( )Voiding Effort
( )Sensation of incomplete emptying ( )Dysuria
( )Dripping ( )Initial Dripping ( )Terminal Dripping
Urinary devices
( ) Toilet ( ) urinals bedpans
( ) Indwelling catheter
( ) Diapers
( ) Absorbent intimate feminine
( ) Catheterization intermittent bladder
( ) External condom collecting device
Complications of urinary tract
( ) Urethral fistula
( ) Cystocele
( ) Prostatic hyperplasia
( ) Urethral Stenosis
( )Hydronephrosis D/E
( ) Urethral diverticulum
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( ) Lithiasis vescial
( ) Renal lithiasis
( ) Renal failure
( ) Lesion of penis
( ) Urinary tract infection
Self-care
Daily water intake __________ Appropriate division of ingestion ( ) Yes ( ) No
Liquid dysphagia ( ) Yes ( ) No Low tolerance for liquids ( ) Yes ( ) No
Dependant on others for toileting ( ) Yes ( ) No
Do you require instruction on how to use the urinary device? ( ) Yes ( ) No
Mobility
Dependant on others ( ) Yes ( ) No Why?_________________________________________________
Impairment: ( ) Bradykinesia ( ) Tremor ( ) Postural instability ( ) Motor complications
Locomotion: ( ) Without Assistance and without support ( ) Locomotion with assistance Which?_______
Falls: ( ) Yes ( ) No ( ) Falls between bed- and bathroom: ( ) Yes ( ) No Risk of falls: ( ) Yes ( ) No Why?
______________________________________________________________________________
Mental function
Cognitive/behavioral disorders: ( ) Yes ( ) No Which: _________________________________
Sleep
Dependent on medication: ( ) Yes ( ) No Wakes from sleep by urinary desire: ( ) Yes ( ) No
Sleep disorders: ( ) Yes ( ) No
Housing conditions
Live alone ( ) Yes ( ) No Accessible bathroom ( ) Yes ( ) No
It is able to maintain a safe environment without help? ( ) Yes ( ) No
Has made modification to the bathroom ( ) Yes ( ) No What? __________________________________
Needs to modify the bathroom/home ( ) Yes ( ) No What?_________________________________
Community, social, and civic life
Impact on labor activities related to genitourinary disorders ( ) Yes ( ) No ( ) Not applicable
Impact on leisure activities related to genitourinary disorders ( ) Yes ( ) No
Impact on quality of life related to genitourinary disorders ( ) Yes ( ) No
Have financial resources for modifications, medicines, and urinary devices? ( ) Yes ( ) No
Nursing diagnoses Nursing interventions
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Evaluation of bladder symptoms in patients with PD is complex because it involves investi‐
gation of urinary, gynecological/urological, cognitive/behavioral, and sleep symptoms, as
well as mobility/accessibility and quality of life. Thus, nurse evaluations should focus on
several aspects that may contribute to these changes in order to propose appropriate inter‐
ventions. Some measurement scales may be used, including the Overactive Bladder ques‐
tionnaire (OAB‐q) [53], Questionnaire on Pelvic Organ Function [54], and the Scale for
Outcomes in Parkinson's disease (SCOPA‐AUT) [55].
Nursing assessment for sleep disorders in patients with Parkinson's disease
Date: _____/_____/_______
Personal data
Name: _______________ Age: ___ Sex: ( ) Female ( ) Male Family/Caregiver:___________________




Complaint: _______________________________ Onset of symptoms of sleep disorder: ___________
Use medication to sleep? ( ) yes ( ) no Impact on quality of life of the patient: ( ) yes ( ) no
Has sleep routine? ( ) yes ( ) no Impact on quality of life of the family: ( ) yes ( ) no
Sleep disorders related to motor symptoms
Difficulty with movement in bed: ( ) Yes ( ) No Morning dystonia: ( ) Yes ( ) No
Tremors that compromise the quality of sleep: ( ) Yes ( ) No Restless leg syndrome: ( ) Yes ( ) No
Sleep disorders related to nonmotor symptoms
Hallucinations: ( ) Yes ( ) No Mental confusion: ( ) Yes ( ) No
Sleep apnoea/difficulty breathing: ( ) Yes ( ) No Pain: ( ) Yes ( ) No
Nocturia: ( ) Yes ( ) No
Specific symptoms of sleep disorders
Initial insomnia: ( ) Yes ( ) No Sleep-talking: ( ) Yes ( ) No
Terminal insomnia: ( ) Yes ( ) No Nightmares: ( ) Yes ( ) No
Nonrestorative sleep: ( ) Yes ( ) No Vivid dreams: ( ) Yes ( ) No
Specific symptoms of daytime sleep disorders
Sleeping unexpectedly during the day: ( ) Yes ( ) No Sleep while talking: ( ) Yes ( ) No
Sleeping while watching TV: ( ) Yes ( ) No Sleep while sitting: ( ) Yes ( ) No
Difficulty staying awake during the day: ( ) Yes ( ) No
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Nursing diagnoses Nursing interventions
Evaluations of symptoms that cause sleep disorders should be approached with care and cover
various related aspects, including motor/nonmotor function and night/day sleep disorders.
Measurement scales can be used for this assessment and may include those recommended by
the Movement Disorders Society Task Force: the PD sleep scale (PDSS), Pittsburgh sleep
quality index (PSQI), SCOPA‐sleep (SCOPA), and the Epworth sleepiness scale (ESS) [56]. We
also emphasize that the PDSS scale has been revised and the PDSS‐2 version has been
validated [57].
Nursing assessment for orthostatic hypotension in patients with Parkinson's disease
Date: _____/_____/_______
Personal data
Name: _________________ Age: ___ Sex: ( ) Female ( ) Male Family/Caregiver:________________
Date of onset of symptoms of Parkinson's disease: _________________________________________
Concomitant diseases: _______________________________________________________________
Daily medications: ___________________________________________________________________
Autonomic scale for outcomes in Parkinson's disease (SCOPA-AUT): Hypotension section
In the past month, when standing up, have you had the feeling of either becoming light-headed, not seeing properly,
or not thinking clearly?
( ) Never ( ) Sometimes ( ) Regularly ( ) Often
In the past month, did you become light-headed after standing for sometime?
( ) Never ( ) Sometimes ( ) Regularly ( ) Often
Have you fainted in the past six months?
( ) Never ( ) Sometimes ( ) Regularly ( ) Often
Composite Autonomic Symptom Scale (COMPASS 31): Hypotension section [59]
1. In the past year, have you ever felt faint, dizzy, “goofy”, or had difficulty thinking soon after standing up from a
sitting or lying position? (1) Yes (2) No
2. When standing up, how frequently do you get these feelings or symptoms?
(1) Rarely (2) Occasionally (3) Frequently (4) Almost Always
3. How would you rate the severity of these feelings or symptoms?
(1) Mild (2) Moderate (3) Severe
4. In the past year, have these feelings or symptoms that you have experienced:
(1) Gotten much worse (2) Gotten somewhat worse (3) Stayed about the same
(4) Gotten somewhat better (5) Gotten much better (6) Completely gone
Physical Examination
Blood pressure (BP) lying:_____X_____mmHg
BP in orthostasis:____X___mmHg (immediately)
Cardiac frequency (CF) lying:___hpm
CF in orthostasis:___hpm (immediately)
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BP in orthostasis: ___X___mmHg (after 3min) CF in orthostasis:___hpm (after 3min)
*Criteria for orthostatic hypotension: when a person moves from a supine to a sitting or a standing position occurs a
decline of >20 mmHg in systolic blood pressure or a decline of >10 mmHg in diastolic blood pressure. The decrease
must be present within 3 minutes after the postural change [60].
Nursing diagnoses Nursing interventions
Evaluation of orthostatic hypotension in patients with PD should be part of nursing protocol.
Different measurement scales can be used, including those recommended by the Movement
Disorders Society Task Force [58]: SCOPA‐AUT and the Composite Autonomic Symptom
Scale (COMPASS) [59]. Nursing care can be based on “Clinical Practice Guidelines: Patient
Self‐Management of BP Instability in Multiple System Atrophy, Parkinson's Disease and Other
Neurological Disorders” [60].
Nursing assessment for medication adherence in patients with Parkinson's disease
Date: _____/_____/_______
Personal Data
Name: ________________ Age: ___ Sex: ( ) Female ( ) Male Family/Caregiver:_________________
Date of onset of symptoms of Parkinson's disease: __________________________________________
Daily medication
Number of pills/time of ingestion Number of pills/time of ingestion Medication action/Side effects
Time-action:_______________________
( ) dyskinesia ( ) wearing-off
( ) ON/OFF ( ) nausea/vomiting
( ) No side effect ( ) Other:
( ) take the pills with food/protein
Morisky Medication Adherence Scale: High adherence (8 points), medium (6 to < 8 points) and low adherence (<6
points) [61]
1) Do you sometimes forget to take your pills for PD? ( 0 ) Yes ( 1 ) No
2) People sometimes miss taking their medications for reasons other than
forgetting. Thinking over the past two weeks, were there any days when
you did not take your medicine?
( 0 ) Yes ( 1 ) No
3) Have you ever cut back or stopped taking your medicine without
telling your doctor because you felt worse when you took it?
( 0 ) Yes ( 1 ) No
4) When you travel or leave home, do you sometimes forget to bring
along your medicine?
( 0 ) Yes ( 1 ) No
5) Did you take all your medicine yesterday? ( 0 ) Yes ( 1 ) No
6) When you feel like your symptoms are under control, do you
sometimes stop taking your medicine?
( 0 ) Yes ( 1 ) No
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7) Taking medicine every day is a real inconvenience for some people. Do
you ever feel hassled about sticking to your treatment plan?
( 0 ) Yes ( 1 ) No
8) How often do you have difficulty remembering to take all your
medicine?
( )Never/rarely ( )Once in a while
( )Sometimes ( )Usually
( )All the time
Self-care
Dependent on others for management of medications? ( ) yes ( ) no
( )Dysphagia for liquids ( )Dysphagia for solids: capsules/tablets ( )Change the consistency of medications
Mental function
Cognitive disorders: ( ) Yes ( ) No What: __________________________________________________
Neuropsychiatric disorders: ( ) No ( ) Visual hallucinations ( ) Auditory hallucinations ( ) Impulsivity
( ) Hypersexuality ( ) Anxiety
Housing conditions
Live alone ( ) Yes ( ) No Easy access to where medications are stored ( ) Yes ( ) No
Community, social, and civic life
Impact on labor activities related to drug use? ( ) Yes ( ) No ( ) Not applicable
Impact on leisure activities related to drug use? ( ) Yes ( ) No
Impact on quality of life related to drug use? ( ) Yes ( ) No
Have financial resources to purchase medicines? ( ) Yes ( ) No
Support and relationships
Requires support of family/caregiver for management of medicines? ( ) Yes ( ) No
Resources to remember to take medication (box organizer, alarms, cellular)? ( )Yes ( ) No
Have financial resources to purchase medicines? ( ) Yes ( ) No
Acquires the medications by the public health system? ( ) Yes ( ) No
Suffers consequences of insufficient supply of medicines? ( ) Yes ( ) No ( ) Public services ( ) Private service
Nursing diagnoses Nursing interventions
Evaluation of medication adherence should consider aspects related to medication (expect‐
ed, adverse, and side effects; action time; costs; etc.), other symptoms of PD (dysphagia, cog‐
nitive/neuropsychiatric disorders), impact on the quality of life, and family support/
caregiver for management of treatment. The scale most commonly used in research and clin‐
ical practice is the Morisky Medical Adherence Scale (MMAS) [62–64].




The important role of nurses in the multidisciplinary care of patients with PD is obvious, and
training of increasing numbers of professionals to meet the growing demand is an absolute‐
ly plausible goal.
Health actions based on comprehensive care centered on patients and their families, based on
ethical, legal, operational, and theoretical premises of the profession and grounded in the
concepts of prevention, promotion, treatment, and rehabilitation, provide quality and scientific
rigor for patient care. These actions may help to improve the quality of life of individuals with
neurodegenerative diseases that are multisystem, incurable, and often disabling.
Development of an organizational chart of the motor and nonmotor symptoms of PD and a
survey of the main diagnoses/outcomes and nursing interventions based on a standardized
language can direct clinical reasoning of professionals who care for these patients. Moreover,
these tools may enable the development and/or improvement of clinical protocols that underlie
the systematization of nursing care.
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